Clinical Trials Directory

Trials / Completed

CompletedNCT00589225

Primary Hyperoxaluria Mutation Genotyping

Correlation of Disease Expression With Specific Genetic Mutations in Primary Hyperoxaluria

Status
Completed
Phase
Study type
Observational
Enrollment
902 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.

Detailed description

During your study visit, we will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Primary Hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with Primary Hyperoxaluria, and family members of Primary Hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.

Conditions

Interventions

TypeNameDescription
GENETICGenetic AnalysisWe will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing.

Timeline

Start date
2003-12-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2008-01-09
Last updated
2016-07-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00589225. Inclusion in this directory is not an endorsement.